Dr. Roy M. Gulick, MD, MPH

Dr. Gulick practices at Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network.

Dr. Gulick's NPI, 1881731172, was assigned on January 30, 2007. Dr. Gulick graduated from Vagelos College of Physicians and Surgeons in 1986. Dr. Gulick holds New York license 173938.

Dr. Gulick's primary practice is Jamaica Hospital Medical Center, at 89th Avenue and Van Wyck Expressway, Jamaica, NY 11418 in Queens County. The practice phone is (718) 262-6000. Dr. Gulick also practices at Jamaica Hospital Medical Center, 89- Van Wyck Expy, Richmond Hill, NY 11418.

Dr. Gulick's primary practice is Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network. Dr. Gulick is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gulick practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Gulick's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Gulick is board certified in infectious disease by the American Board of Internal Medicine. Dr. Gulick is licensed in New York.

Dmand AI lists hiv/aids among the conditions Dr. Gulick treats.

CMS data shows 80 Medicare services from Dr. Gulick across 3 procedure codes in 2024, for 42 Medicare patients. Medicare paid $8,021 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 42 Medicare patients who saw Dr. Gulick in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 33% are also on Medicaid. Their average risk score is 3.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gulick's median patient age at 64, with 18% women.

In 2024, Dr. Gulick wrote 166 Medicare Part D claims. 55% of them were for generic drugs. CMS names the drug for 102 of them, across 6 drugs with 11 or more claims each, at $239,708 in total drug cost. In 2023, CMS named 87 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gulick for performance year 2024, reported through an alternative payment model (APM). Dr. Gulick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 175 papers to Dr. Gulick, published from 2001 to 2025. 2020 was the busiest year, with 11. The most frequent topics are HIV Infections, Anti-HIV Agents and HIV-1. Dr. Gulick has published most often in J Infect Dis. Dr. Gulick's most frequent co-authors are Timothy James Wilkin, MD, Eric S. Daar, MD and Joseph J. Eron, MD.

Dmand AI links Dr. Gulick to 10 clinical trials, 4 of them phase 2 studies. Conditions studied include HIV Infections, Lentivirus Infections and Acquired Immunodeficiency Syndrome. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 7.

Dmand AI lists 16 awards for Dr. Gulick, most recently NCQA PCMH in 2015.

Dr. Gulick graduated from Vagelos College of Physicians and Surgeons in 1986.

Dr. Gulick is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.